Manufacturer
Legacy Pharmaceutical Packaging, LLC
16 drugs, 37 product strengths, 10 recalls on record.
Drugs Legacy Pharmaceutical Packaging, LLC makes
Amlodipine-2.6%Generic · 33 makersPharmacies pay from$0.3017 open recallsSertraline+0.8%Generic · 42 makersPharmacies pay from$0.852 open recallsEscitalopram-0.9%Generic · 38 makersPharmacies pay from$1.17Fluoxetine-0.3%Generic · 53 makersPharmacies pay from$0.88Clopidogrel-0.6%Generic · 33 makersPharmacies pay from$1.411 open recallFinasteride-0.3%Generic · 30 makersPharmacies pay from$1.312 open recallsIbuprofen+1.5%Generic · 240 makersPharmacies pay from$1.019 open recallsMetformin+2.2%Generic · 65 makersPharmacies pay from$0.44Being discontinued21 open recallsMetoprolol+1.0%Generic · 65 makersPharmacies pay from$0.48Being discontinued9 open recallsLisinopril-1.8%Generic · 31 makersPharmacies pay from$0.421 open recallHydrochlorothiazide-1.0%Generic · 41 makersPharmacies pay from$0.34Being discontinued28 open recallsFamotidine-2.3%Generic · 123 makersPharmacies pay from$0.612 open recallsGlipizide-4.9%Generic · 28 makersPharmacies pay from$0.99Lovastatin+3.9%Generic · 17 makersPharmacies pay from$1.06Enalapril+16.7%Generic · 29 makersPharmacies pay from$1.885 open recallsHydrochlorothiazide / lisinopril-0.8%Generic · 24 makersPharmacies pay from$0.88
Recalls
Class IIOngoingJan 3, 2024Sertraline TabletsCGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.Legacy Pharmaceutical Packaging LLC · D-0205-2024Class IIITerminatedOct 7, 2020Metformin Hydrochloride Tablets USPPresence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.Legacy Pharmaceutical Packaging LLC · D-1626-2020Class IIOngoingMay 8, 2019Losartan Potassium TabletsCGMP Deviations: Detection of trace amounts of N-Methylnitrosobutyric acid (NMBA) impurity found in the Active Pharmaceutical Ingredient (API)Legacy Pharmaceutical Packaging LLC · D-1263-2019Class IITerminatedApr 10, 2019Losartan Potassium TabletsCGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected.Legacy Pharmaceutical Packaging LLC · D-1075-2019Class IIOngoingMar 27, 2019Losartan Potassium TabletsCGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detectedLegacy Pharmaceutical Packaging LLC · D-1048-2019Class IIOngoingMar 27, 2019Losartan Potassium TabletsCGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detectedLegacy Pharmaceutical Packaging LLC · D-1049-2019Class IIOngoingMar 27, 2019Losartan Potassium TabletsCGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detectedLegacy Pharmaceutical Packaging LLC · D-1050-2019Class IITerminatedMar 29, 2017ATENOLOL TabletsPresence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.Legacy Pharmaceutical Packaging LLC · D-0606-2017Class IIITerminatedJun 12, 2013LorazepamLabeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009Legacy Pharmaceutical Packaging LLC · D-580-2013Class IITerminatedMay 22, 2013Walmart Amlodipine Besylate TabletsLabeling: Label Error on Declared Strength-The recalled product has a misprint on the Amoldipine 10 mg label, 5 mg is listed in the USP description. Tablet strength is...Legacy Pharmaceutical Packaging LLC · D-319-2013
About Legacy Pharmaceutical Packaging, LLC
No comments yet. Questions, tips, what worked for you - start the conversation.